Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 24 February, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Omkar Speciality Chemicals Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 24, 2025, 10:42 pm

Market Cap 15.2 Cr.
Current Price 7.36
High / Low 11.6/5.65
Stock P/E
Book Value 83.0
Dividend Yield0.00 %
ROCE10.5 %
ROE%
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Omkar Speciality Chemicals Ltd

Competitors of Omkar Speciality Chemicals Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
HP Adhesives Ltd 475 Cr. 51.9 123/47.324.6 19.20.58 %17.7 %12.6 % 2.00
Haryana Leather Chemicals Ltd 39.7 Cr. 80.8 124/56.89.63 87.21.24 %8.96 %7.25 % 10.0
Hardcastle & Waud Mfg Co Ltd 47.9 Cr. 705 1,355/56327.4 6630.00 %7.00 %5.98 % 10.0
Grauer & Weil (India) Ltd 3,867 Cr. 85.3 120/72.224.1 19.20.59 %26.1 %19.6 % 1.00
DMCC Speciality Chemicals Ltd 769 Cr. 306 453/24536.9 85.40.33 %7.55 %2.89 % 10.0
Industry Average11,550.58 Cr726.8346.86173.820.37%13.99%10.73%6.44

All Competitor Stocks of Omkar Speciality Chemicals Ltd

Quarterly Result

MetricJun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022
Sales 10.7018.9714.4312.795.1416.8612.1610.977.364.236.345.053.74
Expenses 10.3117.8814.1014.834.8613.809.2010.787.766.556.218.164.69
Operating Profit 0.391.090.33-2.040.283.062.960.19-0.40-2.320.13-3.11-0.95
OPM % 3.64%5.75%2.29%-15.95%5.45%18.15%24.34%1.73%-5.43%-54.85%2.05%-61.58%-25.40%
Other Income 0.310.040.010.081.010.070.554.160.020.720.010.210.12
Interest 1.151.241.471.081.251.591.521.211.431.491.571.581.69
Depreciation 1.691.661.981.251.030.980.980.570.470.470.400.440.39
Profit before tax -2.14-1.77-3.11-4.29-0.990.561.012.57-2.28-3.56-1.83-4.92-2.91
Tax % -1.40%-67.23%-31.51%-26.11%-34.34%71.43%39.60%-0.39%0.00%0.00%0.00%0.00%0.00%
Net Profit -2.17-2.96-4.09-5.42-1.340.160.612.58-2.28-3.56-1.84-4.92-2.90
EPS in Rs -1.05-1.44-1.99-2.63-0.650.080.301.25-1.11-1.73-0.89-2.39-1.41

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MetricMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022TTM
Sales 1071672022101933193171984357452319
Expenses 851341651771642742592414457382926
Operating Profit 21333633294557-43-1-07-6-6
OPM % 20%20%18%16%15%14%18%-22%-3%-0%16%-25%-32%
Other Income 146659-161-49120511
Interest 5871211172226155666
Depreciation 26662411887422
Profit before tax 152329212033-137-127-12-113-13-13
Tax % 31%29%28%30%12%33%20%18%-46%-29%36%0%
Net Profit 101621151822-109-104-17-152-13-13
EPS in Rs 5.178.3910.617.458.7010.78-53.09-50.47-8.19-7.100.98-6.12-6.42
Dividend Payout % 19%15%14%20%17%14%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2011-20122012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-2022
YoY Net Profit Growth (%)60.00%31.25%-28.57%20.00%22.22%-595.45%4.59%83.65%11.76%113.33%-750.00%
Change in YoY Net Profit Growth (%)0.00%-28.75%-59.82%48.57%2.22%-617.68%600.04%79.07%-71.89%101.57%-863.33%

Omkar Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2011-2012 to 2021-2022.

Growth

Compounded Sales Growth
10 Years:-18%
5 Years:-41%
3 Years:-19%
TTM:-59%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:16%
TTM:-345%
Stock Price CAGR
10 Years:-21%
5 Years:14%
3 Years:-37%
1 Year:-13%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 3:02 pm

MonthMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Equity Capital 202020202121212121212121
Reserves 7386107118142161-23-146-169-183-179-192
Borrowings 4578118154176186181233230233228226
Other Liabilities 3533385050801292826261718
Total Liabilities 172217283342389447307136107978672
Fixed Assets 213644436878837668532826
CWIP 18314069107113000000
Investments 12111414140110010
Other Assets 1331481872171992422244938445846
Total Assets 172217283342389447307136107978672

Reserves and Borrowings Chart

Cash Flow

MonthMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Cash from Operating Activity +4-002453-91072614-161
Cash from Investing Activity +-45-32-46-43-7612-120-64112170
Cash from Financing Activity +8222361517-81635-14-5-1-1
Net Cash Flow41-10-10-3-6-63-3-10-00

Free Cash Flow

MonthMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Free Cash Flow-24.00-45.00-82.00-121.00-147.00-141.00-124.00-276.00-231.00-233.00-221.00-232.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Debtor Days93841111481291179019743011133
Inventory Days14716817015614999110837311840
Days Payable106817394968118432259148139215
Cash Conversion Cycle13517220921018113516-5-147-86-10-143
Working Capital Days18015618318413914848-26-119-38165285
ROCE %22%19%17%12%10%14%18%-34%-8%-8%7%-11%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022
Promoters27.62%27.62%27.62%27.62%27.62%27.62%14.71%27.62%17.62%17.62%14.71%14.71%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.06%0.00%0.01%0.00%0.06%0.06%
DIIs0.01%0.03%0.01%0.01%0.01%0.01%0.01%0.01%0.00%0.01%0.01%0.01%
Public72.38%72.35%72.38%72.38%72.38%72.38%85.22%72.38%82.36%82.37%85.22%85.22%
No. of Shareholders19,72819,50719,08718,96518,67818,27319,43017,46119,15219,31819,43019,430

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 16Mar 15Mar 14Mar 13Mar 12
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 14.8812.036.9110.478.15
Diluted EPS (Rs.) 14.8812.036.5910.468.15
Cash EPS (Rs.) 19.2616.8213.0513.8811.03
Book Value[Excl.RevalReserv]/Share (Rs.) 94.9981.9269.9164.7453.71
Book Value[Incl.RevalReserv]/Share (Rs.) 94.9981.9269.9164.7453.71
Revenue From Operations / Share (Rs.) 200.90128.84122.42107.8585.06
PBDIT / Share (Rs.) 39.9625.7923.5322.5318.53
PBIT / Share (Rs.) 35.5820.7717.3919.1215.65
PBT / Share (Rs.) 25.4513.7310.0415.2911.52
Net Profit / Share (Rs.) 14.8811.806.9110.478.15
NP After MI And SOA / Share (Rs.) 14.8811.806.9110.478.15
PBDIT Margin (%) 19.8920.0119.2220.8821.78
PBIT Margin (%) 17.7016.1114.2017.7218.39
PBT Margin (%) 12.6610.658.2014.1713.54
Net Profit Margin (%) 7.409.155.649.719.58
NP After MI And SOA Margin (%) 7.409.155.649.719.58
Return on Networth / Equity (%) 15.6614.409.8816.1715.17
Return on Capital Employeed (%) 24.0818.4516.7520.3823.00
Return On Assets (%) 5.255.063.366.246.73
Long Term Debt / Equity (X) 0.480.350.470.420.24
Total Debt / Equity (X) 1.061.191.391.140.90
Asset Turnover Ratio (%) 0.640.480.620.770.85
Current Ratio (X) 0.970.831.081.321.33
Quick Ratio (X) 0.610.470.650.810.82
Inventory Turnover Ratio (X) 2.221.491.382.052.60
Dividend Payout Ratio (NP) (%) 10.0812.7121.7114.3215.33
Dividend Payout Ratio (CP) (%) 7.788.9111.4910.8011.32
Earning Retention Ratio (%) 89.9287.2978.2985.6884.67
Cash Earning Retention Ratio (%) 92.2291.0988.5189.2088.68
Interest Coverage Ratio (X) 4.043.663.225.884.49
Interest Coverage Ratio (Post Tax) (X) 2.522.681.953.732.98
Enterprise Value (Cr.) 556.39517.22461.39345.22178.59
EV / Net Operating Revenue (X) 1.351.951.921.631.07
EV / EBITDA (X) 6.779.759.997.814.91
MarketCap / Net Operating Revenue (X) 0.861.251.201.060.69
Retention Ratios (%) 89.9187.2878.2885.6784.66
Price / BV (X) 1.841.972.101.771.10
Price / Net Operating Revenue (X) 0.861.251.201.060.69
EarningsYield 0.080.070.040.090.13

After reviewing the key financial ratios for Omkar Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 16, the value is 14.88. This value is within the healthy range. It has increased from 12.03 (Mar 15) to 14.88, marking an increase of 2.85.
  • For Diluted EPS (Rs.), as of Mar 16, the value is 14.88. This value is within the healthy range. It has increased from 12.03 (Mar 15) to 14.88, marking an increase of 2.85.
  • For Cash EPS (Rs.), as of Mar 16, the value is 19.26. This value is within the healthy range. It has increased from 16.82 (Mar 15) to 19.26, marking an increase of 2.44.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 94.99. It has increased from 81.92 (Mar 15) to 94.99, marking an increase of 13.07.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 94.99. It has increased from 81.92 (Mar 15) to 94.99, marking an increase of 13.07.
  • For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 200.90. It has increased from 128.84 (Mar 15) to 200.90, marking an increase of 72.06.
  • For PBDIT / Share (Rs.), as of Mar 16, the value is 39.96. This value is within the healthy range. It has increased from 25.79 (Mar 15) to 39.96, marking an increase of 14.17.
  • For PBIT / Share (Rs.), as of Mar 16, the value is 35.58. This value is within the healthy range. It has increased from 20.77 (Mar 15) to 35.58, marking an increase of 14.81.
  • For PBT / Share (Rs.), as of Mar 16, the value is 25.45. This value is within the healthy range. It has increased from 13.73 (Mar 15) to 25.45, marking an increase of 11.72.
  • For Net Profit / Share (Rs.), as of Mar 16, the value is 14.88. This value is within the healthy range. It has increased from 11.80 (Mar 15) to 14.88, marking an increase of 3.08.
  • For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 14.88. This value is within the healthy range. It has increased from 11.80 (Mar 15) to 14.88, marking an increase of 3.08.
  • For PBDIT Margin (%), as of Mar 16, the value is 19.89. This value is within the healthy range. It has decreased from 20.01 (Mar 15) to 19.89, marking a decrease of 0.12.
  • For PBIT Margin (%), as of Mar 16, the value is 17.70. This value is within the healthy range. It has increased from 16.11 (Mar 15) to 17.70, marking an increase of 1.59.
  • For PBT Margin (%), as of Mar 16, the value is 12.66. This value is within the healthy range. It has increased from 10.65 (Mar 15) to 12.66, marking an increase of 2.01.
  • For Net Profit Margin (%), as of Mar 16, the value is 7.40. This value is within the healthy range. It has decreased from 9.15 (Mar 15) to 7.40, marking a decrease of 1.75.
  • For NP After MI And SOA Margin (%), as of Mar 16, the value is 7.40. This value is below the healthy minimum of 8. It has decreased from 9.15 (Mar 15) to 7.40, marking a decrease of 1.75.
  • For Return on Networth / Equity (%), as of Mar 16, the value is 15.66. This value is within the healthy range. It has increased from 14.40 (Mar 15) to 15.66, marking an increase of 1.26.
  • For Return on Capital Employeed (%), as of Mar 16, the value is 24.08. This value is within the healthy range. It has increased from 18.45 (Mar 15) to 24.08, marking an increase of 5.63.
  • For Return On Assets (%), as of Mar 16, the value is 5.25. This value is within the healthy range. It has increased from 5.06 (Mar 15) to 5.25, marking an increase of 0.19.
  • For Long Term Debt / Equity (X), as of Mar 16, the value is 0.48. This value is within the healthy range. It has increased from 0.35 (Mar 15) to 0.48, marking an increase of 0.13.
  • For Total Debt / Equity (X), as of Mar 16, the value is 1.06. This value exceeds the healthy maximum of 1. It has decreased from 1.19 (Mar 15) to 1.06, marking a decrease of 0.13.
  • For Asset Turnover Ratio (%), as of Mar 16, the value is 0.64. It has increased from 0.48 (Mar 15) to 0.64, marking an increase of 0.16.
  • For Current Ratio (X), as of Mar 16, the value is 0.97. This value is below the healthy minimum of 1.5. It has increased from 0.83 (Mar 15) to 0.97, marking an increase of 0.14.
  • For Quick Ratio (X), as of Mar 16, the value is 0.61. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 15) to 0.61, marking an increase of 0.14.
  • For Inventory Turnover Ratio (X), as of Mar 16, the value is 2.22. This value is below the healthy minimum of 4. It has increased from 1.49 (Mar 15) to 2.22, marking an increase of 0.73.
  • For Dividend Payout Ratio (NP) (%), as of Mar 16, the value is 10.08. This value is below the healthy minimum of 20. It has decreased from 12.71 (Mar 15) to 10.08, marking a decrease of 2.63.
  • For Dividend Payout Ratio (CP) (%), as of Mar 16, the value is 7.78. This value is below the healthy minimum of 20. It has decreased from 8.91 (Mar 15) to 7.78, marking a decrease of 1.13.
  • For Earning Retention Ratio (%), as of Mar 16, the value is 89.92. This value exceeds the healthy maximum of 70. It has increased from 87.29 (Mar 15) to 89.92, marking an increase of 2.63.
  • For Cash Earning Retention Ratio (%), as of Mar 16, the value is 92.22. This value exceeds the healthy maximum of 70. It has increased from 91.09 (Mar 15) to 92.22, marking an increase of 1.13.
  • For Interest Coverage Ratio (X), as of Mar 16, the value is 4.04. This value is within the healthy range. It has increased from 3.66 (Mar 15) to 4.04, marking an increase of 0.38.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is 2.52. This value is below the healthy minimum of 3. It has decreased from 2.68 (Mar 15) to 2.52, marking a decrease of 0.16.
  • For Enterprise Value (Cr.), as of Mar 16, the value is 556.39. It has increased from 517.22 (Mar 15) to 556.39, marking an increase of 39.17.
  • For EV / Net Operating Revenue (X), as of Mar 16, the value is 1.35. This value is within the healthy range. It has decreased from 1.95 (Mar 15) to 1.35, marking a decrease of 0.60.
  • For EV / EBITDA (X), as of Mar 16, the value is 6.77. This value is within the healthy range. It has decreased from 9.75 (Mar 15) to 6.77, marking a decrease of 2.98.
  • For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.25 (Mar 15) to 0.86, marking a decrease of 0.39.
  • For Retention Ratios (%), as of Mar 16, the value is 89.91. This value exceeds the healthy maximum of 70. It has increased from 87.28 (Mar 15) to 89.91, marking an increase of 2.63.
  • For Price / BV (X), as of Mar 16, the value is 1.84. This value is within the healthy range. It has decreased from 1.97 (Mar 15) to 1.84, marking a decrease of 0.13.
  • For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.25 (Mar 15) to 0.86, marking a decrease of 0.39.
  • For EarningsYield, as of Mar 16, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 15) to 0.08, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Omkar Speciality Chemicals Ltd as of February 24, 2025 is: ₹152.39

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 24, 2025, Omkar Speciality Chemicals Ltd is Undervalued by 1,970.52% compared to the current share price ₹7.36

Default values used*: Default value of 15 for Stock P/E is used, Default value of 15% for ROE is used

Intrinsic Value of Omkar Speciality Chemicals Ltd as of February 24, 2025 is: 186.83

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 24, 2025, Omkar Speciality Chemicals Ltd is Undervalued by 2,438.45% compared to the current share price ₹7.36

Default values used*: Default value of 15 for Stock P/E is used, Default value of 15% for ROE is used

Last 5 Year EPS CAGR: 22.60%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
    1. The stock has a low average ROCE of 4.83%, which may not be favorable.
    2. The stock has a high average Working Capital Days of 108.75, which may not be favorable.
    3. The stock has a high average Cash Conversion Cycle of 55.58, which may not be favorable.
    4. The company has higher borrowings (174.00) compared to reserves (-17.08), which may suggest financial risk.
    5. The company has not shown consistent growth in sales (146.15) and profit (-13.00).

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Omkar Speciality Chemicals Ltd:
      1. Net Profit Margin: 7.4%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 24.08% (Industry Average ROCE: 13.99%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 15.66% (Industry Average ROE: 10.73%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 2.52
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 0.61
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 0 (Industry average Stock P/E: 46.86)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 1.06
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Omkar Speciality Chemicals Ltd. is a Public Limited Listed company incorporated on 24/02/2005 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH2005PLC151589 and registration number is 151589. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 22.98 Cr. and Equity Capital is Rs. 20.58 Cr. for the Year ended 31/03/2022.
    INDUSTRYADDRESSCONTACT
    Chemicals - Speciality - OthersMahalasa Narayani, Thane Maharashtra 421503info@omkarchemicals.com
    http://www.omkarchemicals.com
    Management
    NamePosition Held
    Mr. Pravin S HerlekarChairman & Managing Director
    Mr. Subhash AmbatkarExecutive Director
    Mrs. Sanjivani S PatareIndependent Director
    Ms. Archana DakhaleIndependent Director
    Mr. Kannan ThevarNon Exe.Non Ind.Director

    FAQ

    What is the latest intrinsic value of Omkar Speciality Chemicals Ltd?

    Let's break down Omkar Speciality Chemicals Ltd's intrinsic value simply:

    We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

    As of 24 February 2025:

    • Calculated Fair Value: ₹152.39
    • Current Market Price: ₹7.36
    • Variance: 1970.52% higher

    This suggests Omkar Speciality Chemicals Ltd is currently undervalued by 1970.52%. For context:

    • Market Cap: 15.2 Cr.
    • 52-Week Range: 11.6/5.65
    • Reserves (Mar 2022): ₹-192 Cr
    • Liabilities: 72 Cr

    Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

    What is the Market Cap of Omkar Speciality Chemicals Ltd?

    The Market Cap of Omkar Speciality Chemicals Ltd is 15.2 Cr..

    What is the current Stock Price of Omkar Speciality Chemicals Ltd as on 24 February 2025?

    The current stock price of Omkar Speciality Chemicals Ltd as on 24 February 2025 is ₹7.36.

    What is the High / Low of Omkar Speciality Chemicals Ltd stocks in FY 2024-2025?

    In FY 2024-2025, the High / Low of Omkar Speciality Chemicals Ltd stocks is 11.6/5.65.

    What is the Stock P/E of Omkar Speciality Chemicals Ltd?

    The Stock P/E of Omkar Speciality Chemicals Ltd is .

    What is the Book Value of Omkar Speciality Chemicals Ltd?

    The Book Value of Omkar Speciality Chemicals Ltd is 83.0.

    What is the Dividend Yield of Omkar Speciality Chemicals Ltd?

    The Dividend Yield of Omkar Speciality Chemicals Ltd is 0.00 %.

    What is the ROCE of Omkar Speciality Chemicals Ltd?

    The ROCE of Omkar Speciality Chemicals Ltd is 10.5 %.

    What is the ROE of Omkar Speciality Chemicals Ltd?

    The ROE of Omkar Speciality Chemicals Ltd is %.

    What is the Face Value of Omkar Speciality Chemicals Ltd?

    The Face Value of Omkar Speciality Chemicals Ltd is 10.0.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Omkar Speciality Chemicals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE